CLS Holdings USA, Inc. (OTC US:CLSH) is a diversified cann-a-bis company that acts as an integrated cann-a-bis producer and retailer through its Oasis Cann-a-bis subsidiaries in Nevada and plans to expand to other states. CLS stands for “Cann-a-bis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cann-a- and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. https://www.clsholdingsinc.com/
Today, the company released a press release reviewing the financial and operational highlights that made 2021 the most successful and transformational year to date, and releases its initial 2022 outlook.
2021 Highlights and 2022 Outlook:
1. Despite the Nevada cann-a-bis market decelerating in 2021, CLS saw net revenues increase 44% year over year (1)
2. CLS entered into two important joint ventures, which should transform the Company and add substantial revenue at attractive margins (1)
3. City Trees achieved a 6.5% brand market share, according to BDS Analytics, with leading market share positions across key categories (1)
4. For calendar year 2022, we are projecting substantial net revenue growth while maintaining current gross margins and increasing EBITDA (1)
Earlier On Jan 13th, CLS Holdings USA, Inc. (OTC US:CLSH) had announced its operational and financial results for the second quarter of fiscal 2022, ended November 30, 2021. As per the press release, the Company saw meaningful revenue growth for the quarter ended November 30, 2021 with an increase in revenue of 10% compared to the quarter ending November 30, 2020. Revenue growth at City Trees proved to be significant with an increase of 55% compared to last year’s Q2 numbers (2) Company President & COO Andrew Glashow stated “This is a testament to the traction the brand has gained over the past year and its loyal customer base. Our ability to offer a consistently reputable and reliable product at an affordable price has been our strong suit and the brand’s continued growth is a powerful indication of its resonance with consumers (2).
Trading at mere $0.07, CLSH could be highly undervalued. As alwasy, conduct your own due diligence.
Other stocks in similar sector to place on top of watch list are Tilray Inc. (NASDAQ:TLRY), Trulieve Cannabis Corp. (OTC US:TCNNF), Curaleaf Holdings Inc. (OTC US:CURLF), Aurora Cannabis Inc. (NASDAQ:ACB), Canopy Growth Corp. (NASDAQ:CGC), Organigram Holdings Inc. (NASDAQ:OGI), Cronos Group Inc. (NASDAQ:CRON).
Source 1- https://finance.yahoo.com/quote/clsh/
Source 2- https://finance.yahoo.com/news/outperforming-market-cls-holdings-usa-110000736.html
Disclaimer: This is a paid advertisement. WallStreetPR is simply distributing content provided to us by Bullzeyemedia LLC and is not responsible for the production of this content. WallStreetPR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are commercial advertisements and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available to us by BullzeyeMedia LLC is not intended to be, nor does it constitute investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report, and publication. In no event shall WALLSTREETPR be liable to any member, guest, or third party for any damages of any kind arising out of the use of any content or other material published or made available by WALLSTREETPR, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. WallStreetPR.com strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, Wallstreetpr.com, its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. As part of that content, readers, subscribers, and website viewers are expected to read the full disclaimers and financial disclosures statement that can be found on our website by visiting WallStreetPR.com/Disclaimer. WallStreetPR.com has been compensated $750 for advertisement services on CLSH by a 3rd party BullzeyeMedia LLC. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.